Are cephalosporins superior to penicillin for treatment of acute streptococcal pharyngitis?

Clinical Infectious Diseases

Volumn 38, Issue 11, 2004, Pages 1535-1537

  Bisno, Alan L ^a,b  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFADROXIL; CEPHALOSPORIN; LORACARBEF; PENICILLIN G;

CLINICAL TRIAL; DRUG EFFICACY; FOLLOW UP; HUMAN; NOTE; PHARYNGITIS; PRIORITY JOURNAL; STREPTOCOCCUS; STREPTOCOCCUS INFECTION; TREATMENT FAILURE;

CEPHALOSPORINS; HUMANS; PENICILLINS; PHARYNGITIS; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS;

EID: 2942623846     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/392520     Document Type: Note

References (17)

1. Casey JR, Pichichero M. Meta-analysis of cephalosporins versus penicillin for treatment of group A streptococcal tonsillopharyngitis in adults. Clin Infect Dis 2004; 38:1526-34 (in this issue).
2. Pichichero ME, Margolis PA. A comparison of cephalosporins and penicillins in the treatment of group A beta-hemolytic streptococcal pharyngitis: a meta-analysis supporting the concept of microbial copathogenicity. Pediatr Infect Dis J 1991; 10:275-281.
3. Shulman ST, Gerber MA, Tanz RR, Markowitz M. Streptococcal pharyngitis: the case for penicillin therapy. Pediatr Infect Dis J 1994; 13:1-7.
4. Markowitz M, Gerber MA, Kaplan EL. Treatment of streptococcal pharyngotonsillitis: reports of penicillin's demise are premature. J Pediatr 1993; 123:679-85.
5. Kaplan EL, Gastanaduy AS, Huwe BB. The role of the carrier in treatment failures after antibiotic therapy for group A streptococci in the upper respiratory tract. J Lab Clin Med 1981; 98:326-35.
6. Gerber MA, Tanz RR, Kabat W, et al. Potential mechanisms for failure to eradicate group A streptococci from the pharynx. Pediatrics 1999; 104:911-7.
7. Nemeth MA, McCarty J, Gooch WM III, Henry D, Keyserling CH, Tack KJ. Comparison of cefdinir and penicillin for the treatment of streptococcal pharyngitis. Cefdinir Pharyngitis Study Group. Clin Ther 1999; 21:1873-81.
8. Brink WR, Rammelkamp CH Jr, Denny FW, Wannamaker LW. Effect of penicillin and aureomycin on the natural course of streptococcal tonsillitis and pharyngitis. Am J Med 1951; 10:300-8.
9. McCarty J. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in an adult population. Am J Med 1992; 92:74S-79S.
10. McCarty J, Hernon Y, Linn L, Therasse DG, Molina A, Bleile N. Loracarbef versus penicillin VK in the treatment of streptococcal pharyngitis and tonsillitis in adults. Clin Ther 1992; 14:30-40.
11. Smoot JC, Korgenski EK, Daly JA, Veasy LG, Musser JM. Molecular analysis of group A Streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J Clin Microbiol 2002; 40:1805-10.
12. Linder JA, Stafford RS. Antibiotic treatment of adults with sore throat by community primary care physicians: a national survey, 1989-1999. JAMA 2001; 286:1181-6.
13. Webb KH, Needham CA, Kurtz SR. Use of a high-sensitivity rapid strep test without culture confirmation of negative results: 2 years' experience. J Fam Pract 2000; 49:34-8.
14. Little P, Williamson I. Sore throat management in general practice. Fam Pract 1996; 13:317-21.
15. Bisno AL. Diagnosing strep throat in the adult patient: do clinical criteria really suffice? Ann Intern Med 2003; 139:150-1.
16. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 33:757-62.
17. Stollerman GH. Commentary: penicillin therapy for streptococcal pharyngitis - what we have learned in 50 years. Infect Dis Clin Practice 1995; 4:54-7.